Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.

Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F, Matskova L, Ernberg I, Winberg G, Pawson T.

J Biol Chem. 2005 Oct 7;280(40):34133-42. Epub 2005 Aug 8.

2.
3.

Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.

Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R.

Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Review.

PMID:
7812651
4.

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Caldwell RG, Wilson JB, Anderson SJ, Longnecker R.

Immunity. 1998 Sep;9(3):405-11.

5.
6.
7.

Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.

Winberg G, Matskova L, Chen F, Plant P, Rotin D, Gish G, Ingham R, Ernberg I, Pawson T.

Mol Cell Biol. 2000 Nov;20(22):8526-35.

8.

The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.

Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, Longnecker R, Dykstra ML, Pierce SK.

Int Rev Immunol. 2001;20(6):805-35. Review.

PMID:
11913951
9.
10.

Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation.

Schaadt E, Baier B, Mautner J, Bornkamm GW, Adler B.

J Gen Virol. 2005 Mar;86(Pt 3):551-9.

PMID:
15722514
11.
12.

Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.

Scholle F, Longnecker R, Raab-Traub N.

Virology. 2001 Dec 20;291(2):208-14.

13.
14.

Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytes.

Speck P, Ikeda M, Ikeda A, Lederman HM, Longnecker R.

J Biol Chem. 2002 Feb 8;277(6):4123-7. Epub 2001 Dec 3.

15.

The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.

Dawson CW, George JH, Blake SM, Longnecker R, Young LS.

Virology. 2001 Oct 25;289(2):192-207.

16.

MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.

Mukherjee P, Tinder TL, Basu GD, Gendler SJ.

J Leukoc Biol. 2005 Jan;77(1):90-9. Epub 2004 Oct 28.

PMID:
15513966
17.

The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.

Portis T, Cooper L, Dennis P, Longnecker R.

Front Biosci. 2002 Feb 1;7:d414-26. Review.

PMID:
11815296
18.

Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.

Rechsteiner MP, Bernasconi M, Berger C, Nadal D.

Trends Microbiol. 2008 Nov;16(11):520-7. doi: 10.1016/j.tim.2008.08.007. Epub 2008 Oct 3.

PMID:
18835714
19.
20.

Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis.

Niedobitek G, Kremmer E, Herbst H, Whitehead L, Dawson CW, Niedobitek E, von Ostau C, Rooney N, Grässer FA, Young LS.

Blood. 1997 Aug 15;90(4):1664-72.

Supplemental Content

Support Center